Copyright Reports & Markets. All rights reserved.

Global GMP Plasmid DNA Market Growth (Status and Outlook) 2019-2024

Buy now

Table of Contents

    2019-2024 Global GMP Plasmid DNA Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global GMP Plasmid DNA Market Size 2014-2024
        • 2.1.2 GMP Plasmid DNA Market Size CAGR by Region
      • 2.2 GMP Plasmid DNA Segment by Type
        • 2.2.1 Standard
        • 2.2.2 Ultra-Pure
      • 2.3 GMP Plasmid DNA Market Size by Type
        • 2.3.1 Global GMP Plasmid DNA Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global GMP Plasmid DNA Market Size Growth Rate by Type (2014-2019)
      • 2.4 GMP Plasmid DNA Segment by Application
        • 2.4.1 DNA Vaccines
        • 2.4.2 Gene Therapy
        • 2.4.3 Immunotherapy
        • 2.4.4 Others
      • 2.5 GMP Plasmid DNA Market Size by Application
        • 2.5.1 Global GMP Plasmid DNA Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global GMP Plasmid DNA Market Size Growth Rate by Application (2014-2019)

      3 Global GMP Plasmid DNA by Players

      • 3.1 Global GMP Plasmid DNA Market Size Market Share by Players
        • 3.1.1 Global GMP Plasmid DNA Market Size by Players (2017-2019)
        • 3.1.2 Global GMP Plasmid DNA Market Size Market Share by Players (2017-2019)
      • 3.2 Global GMP Plasmid DNA Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 GMP Plasmid DNA by Regions

      • 4.1 GMP Plasmid DNA Market Size by Regions
      • 4.2 Americas GMP Plasmid DNA Market Size Growth
      • 4.3 APAC GMP Plasmid DNA Market Size Growth
      • 4.4 Europe GMP Plasmid DNA Market Size Growth
      • 4.5 Middle East & Africa GMP Plasmid DNA Market Size Growth

      5 Americas

      • 5.1 Americas GMP Plasmid DNA Market Size by Countries
      • 5.2 Americas GMP Plasmid DNA Market Size by Type
      • 5.3 Americas GMP Plasmid DNA Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC GMP Plasmid DNA Market Size by Countries
      • 6.2 APAC GMP Plasmid DNA Market Size by Type
      • 6.3 APAC GMP Plasmid DNA Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe GMP Plasmid DNA by Countries
      • 7.2 Europe GMP Plasmid DNA Market Size by Type
      • 7.3 Europe GMP Plasmid DNA Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa GMP Plasmid DNA by Countries
      • 8.2 Middle East & Africa GMP Plasmid DNA Market Size by Type
      • 8.3 Middle East & Africa GMP Plasmid DNA Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global GMP Plasmid DNA Market Forecast

      • 10.1 Global GMP Plasmid DNA Market Size Forecast (2019-2024)
      • 10.2 Global GMP Plasmid DNA Forecast by Regions
        • 10.2.1 Global GMP Plasmid DNA Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global GMP Plasmid DNA Forecast by Type
      • 10.8 Global GMP Plasmid DNA Forecast by Application

      11 Key Players Analysis

      • 11.1 Cobra Bio
        • 11.1.1 Company Details
        • 11.1.2 GMP Plasmid DNA Product Offered
        • 11.1.3 Cobra Bio GMP Plasmid DNA Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Cobra Bio News
      • 11.2 Waisman Biomanufacturing
        • 11.2.1 Company Details
        • 11.2.2 GMP Plasmid DNA Product Offered
        • 11.2.3 Waisman Biomanufacturing GMP Plasmid DNA Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Waisman Biomanufacturing News
      • 11.3 Gedeon Richter
        • 11.3.1 Company Details
        • 11.3.2 GMP Plasmid DNA Product Offered
        • 11.3.3 Gedeon Richter GMP Plasmid DNA Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Gedeon Richter News
      • 11.4 Eurogentec
        • 11.4.1 Company Details
        • 11.4.2 GMP Plasmid DNA Product Offered
        • 11.4.3 Eurogentec GMP Plasmid DNA Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Eurogentec News
      • 11.5 VGXI
        • 11.5.1 Company Details
        • 11.5.2 GMP Plasmid DNA Product Offered
        • 11.5.3 VGXI GMP Plasmid DNA Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 VGXI News
      • 11.6 PlasmidFactory
        • 11.6.1 Company Details
        • 11.6.2 GMP Plasmid DNA Product Offered
        • 11.6.3 PlasmidFactory GMP Plasmid DNA Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 PlasmidFactory News
      • 11.7 Kaneka
        • 11.7.1 Company Details
        • 11.7.2 GMP Plasmid DNA Product Offered
        • 11.7.3 Kaneka GMP Plasmid DNA Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Kaneka News
      • 11.8 Delphi Genetics
        • 11.8.1 Company Details
        • 11.8.2 GMP Plasmid DNA Product Offered
        • 11.8.3 Delphi Genetics GMP Plasmid DNA Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Delphi Genetics News
      • 11.9 Nature Technology Corporation
        • 11.9.1 Company Details
        • 11.9.2 GMP Plasmid DNA Product Offered
        • 11.9.3 Nature Technology Corporation GMP Plasmid DNA Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Nature Technology Corporation News
      • 11.10 LakePharma
        • 11.10.1 Company Details
        • 11.10.2 GMP Plasmid DNA Product Offered
        • 11.10.3 LakePharma GMP Plasmid DNA Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 LakePharma News

      12 Research Findings and Conclusion

      GMP plasmid DNA, or GMP Grade Plasmid DNA can be used for direct injection as DNA vaccines, gene therapy, or ex-vivo applications such as cell and gene therapies. Compare with other Plasmid DNA, GMP Plasmid has no animal derived enzymes or organic solvents.

      According to this study, over the next five years the GMP Plasmid DNA market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in GMP Plasmid DNA business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of GMP Plasmid DNA market by product type, application, key companies and key regions.

      This study considers the GMP Plasmid DNA value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Standard
      Ultra-Pure
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      DNA Vaccines
      Gene Therapy
      Immunotherapy
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Cobra Bio
      Waisman Biomanufacturing
      Gedeon Richter
      Eurogentec
      VGXI
      PlasmidFactory
      Kaneka
      Delphi Genetics
      Nature Technology Corporation
      LakePharma

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global GMP Plasmid DNA market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of GMP Plasmid DNA market by identifying its various subsegments.
      Focuses on the key global GMP Plasmid DNA players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the GMP Plasmid DNA with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of GMP Plasmid DNA submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now